Alesco Advisors LLC An ESL Co Acquires Shares of 11,575 The Cooper Companies, Inc. $COO

Alesco Advisors LLC An ESL Co acquired a new stake in The Cooper Companies, Inc. (NASDAQ:COO) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 11,575 shares of the medical device company’s stock, valued at approximately $828,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. DAVENPORT & Co LLC raised its holdings in shares of Cooper Companies by 1,359.7% during the fourth quarter. DAVENPORT & Co LLC now owns 567,203 shares of the medical device company’s stock valued at $46,642,000 after acquiring an additional 528,346 shares during the last quarter. Fluent Financial LLC acquired a new stake in shares of Cooper Companies in the fourth quarter worth approximately $3,517,000. Heartland Advisors Inc. acquired a new stake in shares of Cooper Companies in the fourth quarter worth approximately $15,348,000. Wealth Enhancement Advisory Services LLC increased its position in shares of Cooper Companies by 212.3% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 31,455 shares of the medical device company’s stock worth $2,652,000 after purchasing an additional 21,383 shares in the last quarter. Finally, Assetmark Inc. raised its stake in Cooper Companies by 21.0% in the 4th quarter. Assetmark Inc. now owns 184,410 shares of the medical device company’s stock valued at $15,114,000 after purchasing an additional 31,980 shares during the last quarter. 24.39% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on COO shares. Robert W. Baird dropped their price objective on shares of Cooper Companies from $98.00 to $85.00 and set an “outperform” rating for the company in a research note on Friday, June 5th. Wall Street Zen raised shares of Cooper Companies from a “hold” rating to a “buy” rating in a research note on Sunday, June 21st. Weiss Ratings cut Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a report on Monday, June 8th. JPMorgan Chase & Co. dropped their price target on Cooper Companies from $80.00 to $71.00 and set a “neutral” rating for the company in a research report on Friday, June 5th. Finally, Piper Sandler set a $86.00 price target on Cooper Companies and gave the company an “overweight” rating in a report on Monday, June 1st. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have given a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $81.85.

Cooper Companies Stock Performance

NASDAQ COO opened at $71.01 on Wednesday. The stock has a market cap of $13.85 billion, a PE ratio of 60.18, a P/E/G ratio of 1.87 and a beta of 0.84. The company has a current ratio of 1.27, a quick ratio of 0.78 and a debt-to-equity ratio of 0.23. The Cooper Companies, Inc. has a twelve month low of $58.89 and a twelve month high of $89.83. The stock has a fifty day simple moving average of $66.71 and a 200-day simple moving average of $72.36.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.10 by $0.11. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The firm had revenue of $1.08 billion for the quarter, compared to analyst estimates of $1.05 billion. During the same period in the previous year, the firm earned $0.96 EPS. Cooper Companies’s revenue was up 7.9% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Equities analysts anticipate that The Cooper Companies, Inc. will post 4.63 earnings per share for the current year.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.